Can tumor necrosis factor inhibitors induce sclero-uveitis?;Les anti-Tnf peuvent-ils induire des scléro-uvéites ?

Journal Francais d'Ophtalmologie

Volumn 32, Issue 7, 2009, Pages

  Le Garrec, J ^a   Marcelli, C ^a   Mouriaux, F ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Anti TNF; Medication; Scleritis; Side effects; Uveitis

Indexed keywords

EID: 70350287764     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfo.2009.04.029     Document Type: Article

References (23)

1. Sparsa A. Etanercept. Ann Dermatol Venereol 2005;132: 861-76.
2. Lim LL, Fraunfelder FW, Rosenbaum JT. Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum 2007;56:3248-52.
3. Reddy AR, Backhouse OC. Does etanercept induce uveitis ? Br J Ophthalmol 2003;87:925.
4. Taban M, Dupps WJ, Mandell B, Perez VL. Etanercept (Enbrel)- associated inflammatory eye disease: case report and review of the literature. Ocul Immunol Inflamm 2006;14:145-50.
5. Smith JR, Levinson RD, Holland GN, Jabs DA, Robionson MR, Whitcup SM, et al. Differential efficacity of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum 2001;45:252-7.
6. Tiliakos AN. Ocular inflammation disease in patients with rheumatoid arthritis taking etanercept: is discontinuation of etanercept necessary ? J Rheumatol 2003;30:2727.
7. Kaipiainen-Seppanen O, Leino M. Recurrent uveitis in a patient with juvenile spondyloarthropathy associated with tumor necrosis factor α inhibitors. Ann Rheum Dis 2003;62:88-9.
8. Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, et al. Efficacity of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 2003;48:1093-101.
9. Horneff G, Schmeling H, Biedermann T, Foeldvari I, Ganser G, Girschick HJ, et al. The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis 2004;63:1638-44.
10. Scrivo R, Spadaro A, Spinelli FR, Valesini G. Uveitis following the use of tumor necrosis factor alpha inhibitors: comment on the article by Lim et al. Arthritis Rheum 2008;58:1555-6, author reply 1556-7.
11. Hoang-Xuan T, Robin H. Sclérites. Encycl Méd Chir (Elsevier, Paris). Encyclopédie Pratique de Médecine. 6-0040, 1998, 3 p.
12. Weber M, Pasquali JL. Pathologie de l'appareil locomoteur. In: Flament J, Storck D, editors. Oeil et pathologies générales. Paris: Société Française d'Ophtalmologie et Masson; 1997. p. 523-8.
13. Scleritis in relation to connective tissue disorders. In: Watson PG, Hazleman BL, Pavesio CE, Green WR. (Eds.) The sclera and systemic disorders. Editions Butterworth Heinemann, second edition 2004; 171-6.
14. Brézin A. Examen clinique et explorations complémentaires en présence d'une uvéite, éléments d'orientation diagnostique. Encycl Méd Chir (Elsevier, Paris), Ophtalmologie, 21-220-A20, 1998, 15p.
15. Fraunfelder FW. Ocular side effects associated with biphosphonates. Drugs Today (Barc) 2003;39:829-35.
16. Leung S, Ashar BH, Miller RG. Biphosphonate-associated scleritis: a case report and review. South Med J 2005;98: 733-5.
17. Fraunfelder FW, Fraunfelder FT. Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side Effects. Ophthalmology 2004;111: 1275-9.
18. Fraunfelder FW. Drug-induced ocular inflammatory diseases. Drugs Today (Barc) 2007;43:117-23.
19. Santaella RM, Fraunfelder FW. Ocular adverse effects associated with systemic medications: recognition and management. Drugs 2007;67:75-93.
20. Sfikakis PP, Markomichelakis N. Tumor necrosis factor inhibitors and uveitis: comment on the article by Lim et al. Arthritis Rheum 2008;58:1554-5 [author reply 1556-7].
21. De Vos AF, Van Haren MAC, Verhagen C, Hoekzema R, Kijlstra A. Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci 1994;35:1100-6.
22. De Vos AF, Van Haren MAC, Verhagen C, Hoekzema R, Kijlstra A. Systemic anti-tumor necrosis factor antibody treatment exacerbates endotoxin-induced uveitis in the rat. Exp Eye Res 1995 Feb;61:667-75.
23. Kasner L, Chan C, Whitcup SM, Gery I. The paradoxical effect of tumor necrosis factor alpha (TNFα) in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 1993;34:2911-7.